A billion-dollar real estate project is coming to Morrisville, North Carolina, as developers hope to capitalize on the growing biotechnology industry in the state’s Research Triangle.
GlaxoSmithKline announced the British pharma leader’s intention to leave the sprawling campus in Research Triangle Park, N.C. for the more compact confines of a downtown Durham, N.C. space.
Google’s Verily snapped up Raleigh, N.C.-based SignalPath and the company’s clinical trial management system that is expected to support its own clinical trial and evidence-based platform known as Baseline.
North Carolina’s life sciences ecosystem continues to expand as Amgen announced plans to build a new $550 million biologics manufacturing center in Holly Springs in the Research Triangle Park area.
Gilead Sciences will open the doors to the company’s new operations site in North Raleigh, N.C., as part of a business services center expansion. Gilead’s second-quarter 2021 product sales increased 21 percent year-over-year, primarily driven by the Covid-19 antiviral treatment Veklury (remdesivir).
Moderna Inc. said on June 1 the company had entered into an agreement with Thermo Fisher Scientific for manufacturing and packaging its Covid-19 vaccine, as the U.S. vaccine maker looks to scale up production.
The help wanted signs are up across the biopharma industry. According to BioSpace, companies are opening and expanding facilities, which is good news for job seekers.
Several U.S. states on March 25 announced broad expansions of their Covid-19 vaccine rollouts, with California opening immunizations to all adults aged 50 and older starting April 1 and Florida making anyone 40 and up eligible from March 22.
FUJIFILM selected the town of Holly Springs, North Carolina, as the company’s spot to build the largest cell culture biopharmaceutical production facility in North America.
In New York, like in much of the United States, efforts to get the two vaccines that have so far been authorized into the arms of Americans have moved slower than hoped due to a slew of issues.
